105 related articles for article (PubMed ID: 10659050)
1. Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
Lopalco L; Pastori C; Cosma A; Burastero SE; Capiluppi B; Boeri E; Beretta A; Lazzarin A; Siccardi AG
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):109-15. PubMed ID: 10659050
[TBL] [Abstract][Full Text] [Related]
2. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
[TBL] [Abstract][Full Text] [Related]
3. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi AG; Lopalco L
J Virol; 2005 Jun; 79(11):6848-58. PubMed ID: 15890924
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD4 antibodies are associated with HIV-1 seroconversion and may be detectable before anti-HIV-1 antibodies. The Multicenter AIDS Cohort Study.
Keiser P; Keay S; Wasserman S; Wecksler W
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1919-27. PubMed ID: 1489580
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).
Bao MJ; Geng WQ; Cui HL; Zhang XL; Xu DB; Nian H; Dai D; Wang YN; Shang H
Mol Med Rep; 2012 May; 5(5):1311-7. PubMed ID: 22344547
[TBL] [Abstract][Full Text] [Related]
6. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
[TBL] [Abstract][Full Text] [Related]
7. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
[TBL] [Abstract][Full Text] [Related]
8. Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.
Benjelloun F; Dawood R; Urcuqui-Inchima S; Rochereau N; Chanut B; Verrier B; Lucht F; Genin C; Paul S
AIDS; 2013 Jul; 27(12):1992-5. PubMed ID: 23696073
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
Burastero SE; Gaffi D; Lopalco L; Tambussi G; Borgonovo B; De Santis C; Abecasis C; Robbioni P; Gasparri A; Lazzarin A; Celada F; Siccardi AG; Beretta A
AIDS Res Hum Retroviruses; 1996 Mar; 12(4):273-80. PubMed ID: 8906987
[TBL] [Abstract][Full Text] [Related]
10. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
11. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
Pastori C; Barassi C; Piconi S; Longhi R; Villa ML; Siccardi AG; Clerici M; Lopalco L
J Biol Regul Homeost Agents; 2000; 14(1):15-21. PubMed ID: 10763886
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
[TBL] [Abstract][Full Text] [Related]
13. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
[TBL] [Abstract][Full Text] [Related]
14. HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.
Carrillo J; Restrepo C; Rallón NI; Massanella M; del Romero J; Rodríguez C; Soriano V; Clotet B; Benito JM; Blanco J
AIDS; 2013 Jun; 27(9):1375-85. PubMed ID: 23945502
[TBL] [Abstract][Full Text] [Related]
15. A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
Barassi C; Marenzi C; Pastori C; Longhi R; Lazzarin A; Lopalco L
New Microbiol; 2004 Apr; 27(2 Suppl 1):85-94. PubMed ID: 15646069
[TBL] [Abstract][Full Text] [Related]
16. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.
Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA
J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866
[TBL] [Abstract][Full Text] [Related]
17. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Beretta A; Furci L; Burastero S; Cosma A; Dinelli ME; Lopalco L; DeSantis C; Tambussi G; Carrow E; Sabbatani S; Clerici M; Lazzarin A; Siccardi AG
Immunol Lett; 1996 Jun; 51(1-2):39-43. PubMed ID: 8811343
[TBL] [Abstract][Full Text] [Related]
18. Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1.
Babaahmady K; Bergmeier LA; Lehner T
AIDS; 2008 Jul; 22(11):1267-76. PubMed ID: 18580605
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection.
Schønning K; Joost M; Gram GJ; Machuca R; Nielsen C; Nielsen JO; Hansen JE
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):195-202. PubMed ID: 9665495
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
